European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD)-Reference-Cited by-同舟云学术

European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD)

Published:2017-02 Issue: Volume:98 Page:1-3
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

O’Driscoll Lorraine,Stoorvogel Willem,Théry Clotilde,Buzas Edit,Nazarenko Irina,Siljander Pia,Yáñez-Mó María,Fais Stefano,Giebel Bernd,Yliperttula Marjo

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference14 articles.

1. Comparative analysis of EV isolation procedures for miRNAs detection in serum samples;Andreu;J Extracell Vesicles,2016

2. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression;Corcoran;Prostate,2014

3. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling;Deun;J Extracell Vesicles,2014

4. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes;Kowal;Proc Natl Acad Sci U S A,2016

5. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine;Fais;ACS Nano,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes in the Real World of Medical Aesthetics: A Review;Aesthetic Plastic Surgery;2024-02-05

2. The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients;Cancers;2023-05-23

3. Extracellular vesicles in cancer pros and cons: The importance of the evidence-based medicine;Seminars in Cancer Biology;2022-11

4. Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study;Frontiers in Oncology;2021-10-20

5. Surface-Enhanced Raman Spectroscopy to Characterize Different Fractions of Extracellular Vesicles from Control and Prostate Cancer Patients;Biomedicines;2021-05-20